Skip to main content
SpringerLink
Log in

Antidepressiva

  • Chapter
Kompendium der Psychiatrischen Pharmakotherapie

Zusammenfassung

Antidepressiva sind eine heterogene Gruppe von Pharmaka, die bei depressiven Syndromen unterschiedlicher nosologischer Zuordnung und Charakteristik einen stimmungsaufhellenden und/oder antriebsverbessernden Therapieeffekt haben. Zusätzlich sind sie bei einer Reihe weiterer Störungsbilder wirksam, sodass der Begriff »Antidepressiva« nur einen Teilaspekt ihrer therapeutischen Potenz darstellt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Aan het Rot M, Zarate CA Jr, Charney DS, Mathew SJ (2012) Ketamine for depression: where do we go from here? Biol Psychiatry 72(7): 537–547

    Google Scholar 

  • Appleton KM, Sallis HM, Perry R et al (2015) Omega-3 fatty acids for depression in adults. Cochrane Database Syst Rev 11: CD004692

    Google Scholar 

  • Arnow BA, Blasey C, Williams LM et al (2015) Depression subtypes in predicting antidepressant response: a report from the iSPOT-D Trial. Am J Psychiatry 172(8): 743–750

    Google Scholar 

  • Benkert O (2009) StressDepression. Beck, München

    Google Scholar 

  • Brunoni AR, Valiengo L, Baccaro A et al (2013) The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA Psychiatry 70(4): 383–391

    Google Scholar 

  • Cipriani A, Purgato M, Furukawa TA et al (2012) Citalopram versus other anti-depressive agentsfor depression. Cochrane Database Syst Rev 7: CD006534

    Google Scholar 

  • Cooney GM, Dwan K, Greig CA et al (2013) Exercise for depression. Cochrane Database Syst Rev 9: CD004366

    Google Scholar 

  • Cuijpers P, Sijbrandij M, Koole SL et al (2013) The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry 12(2): 137–148

    Google Scholar 

  • Cuijpers P, Sijbrandij M, Koole SL et al (2014) Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry 13(1): 56–67

    Google Scholar 

  • DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (Hrsg) für die Leitliniengruppe Unipolare Depression (2015) S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung, 2. Aufl. Version 2. www.depression.versorgungsleitlinien.de (Online-Zugriff: 10.03.2016)

  • Diener H-C, Weimar C (Hrsg) (2012) Leitlinien für Diagnostik und Therapie in der Neurologie. Herausgegeben von der Kommission »Leitlinien« der Deutschen Gesellschaft für Neurologie, Thieme, Stuttgart

    Google Scholar 

  • Dold M, Aigner M, Lanzenberger R, Kasper S (2013) Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials. Int J Neuropsychopharmacol 16(3): 557–574

    Google Scholar 

  • Dougherty DD, Rezai AR, Carpenter LL et al (2015) A randomized sham-controlled trial of deep brain stimulation of the ventral capsule/ventral striatum for chronic treatment-resistant depression. Biol Psychiatry 78(4): 240–248

    Google Scholar 

  • Driessen E, Hollon SD, Bockting CL et al (2015) Does publication bias inflate the apparent efficacy of psychological treatment for major depressive disorder? A systematic review and meta-analysis of US National Institutes of Health-funded trials. PLoS One 10(9): e0137864

    Google Scholar 

  • Fava M, Memisoglu A, Thase ME et al (2016) Opioid modulation with buprenorphine/samidorphan as adjunctive treatment for inadequate response to antidepressants: a randomized double-blind placebo-controlled trial. Am J Psychiatry 173(5): 499-508

    Google Scholar 

  • Feder A, Parides MK, Murrough JW et al (2014) Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry 71(6): 681–698

    Google Scholar 

  • Finnerup NB, Attal N, Haroutounian S et al (2015) Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 14(2): 162–173

    Google Scholar 

  • Gartlehner G, Hansen RA, Morgan LC et al (2011) Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med 155(11): 772–875

    Google Scholar 

  • Guidi J, Tomba E, Fava GA (1026) The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: a meta-analysis of the sequential model and a critical review of the literature. Am J Psych 173(2): 128–137

    Google Scholar 

  • Gustafsson H, Nordström A, Nordström P (2015) Depression and subsequent risk of Parkinson disease: a nationwide cohort study. Neurology 84(24): 2422–2429

    Google Scholar 

  • Hackam DG, Mrkobrada M (2012) Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis. Neurology 79(18): 1862–1865

    Google Scholar 

  • Hiemke C, Baumann P, Bergemann N et al (2011) AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry 44(6): 195–235

    Google Scholar 

  • Hollon SD, DeRubeis RJ, Fawcett J et al (2014) Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry 71(10): 1157–1164

    Google Scholar 

  • Hoskins M, Pearce J, Bethell A et al (2015) Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis. Br J Psychiatry 206(2): 93–100

    Google Scholar 

  • Jakubovski E, Varigonda AL, Freemantle N et al (2016) Systematic review and meta-analysis: dose-response relationship of selective serotonin reuptake inhibitors in major depressive disorder. Am J Psychiatry 173(2): 174–183

    Google Scholar 

  • Jarrett RB, Minhajuddin A, Gershenfeld H et al (2013) Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo. JAMA Psychiatry 70(11): 1152–1160

    Google Scholar 

  • Katon W, Pedersen HS, Ribe AR et al (2015) Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study. JAMA Psychiatry 72(6): 612–619

    Google Scholar 

  • Kiosses DN, Ravdin LD, Gross JJ et al (2015) Problem adaptation therapy for older adults with major depression and cognitive impairment: a randomized clinical trial. JAMA Psychiatry 72(1): 22–30

    Google Scholar 

  • Koenen KC, Uddin M, Chang SC et al (2011) SLC6A4 methylation modifies the effect of the number of traumatic events on risk for posttraumatic stress disorder. Depress Anxiety 28(8): 639–647

    Google Scholar 

  • Köhler O, Benros ME, Nordentoft M et al (2014) Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 71(12): 1381–1391

    Google Scholar 

  • Kok RM, Nolen WA, Heeren TJ (2012) Efficacy of treatment in older depressed patients: a systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants. J Affect Disord 141(2–3): 103–115

    Google Scholar 

  • Kupfer DJ (1991) Long-term treatment of depression. J Clin Psychiatry 52(Suppl 5): 28–34

    Google Scholar 

  • Kuyken W, Hayes R, Barrett B et al (2015) Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. Lancet 386(9988): 63–73

    Google Scholar 

  • Lam RW, Levitt AJ, Levitan RD et al (2016) Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder: a randomized clinical trial. JAMA Psychiatry 73(1): 56–63

    Google Scholar 

  • Lapidus KA, Levitch CF, Perez AM et al (2014) A randomized controlled trial of intranasal ketamine in major depressive disorder. Biol Psychiatry 76(12): 970–976

    Google Scholar 

  • Mayo-Wilson E, Dias S, Mavranezouli I et al (2014) Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis. Lancet Psychiatry 1(5): 368–376

    Google Scholar 

  • McAllister-Williams RH, Anderson IM et al (2016) Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial. Lancet Psychiatry 3(2): 117–127

    Google Scholar 

  • Mead GE, Hsieh CF, Lee R et al (2013) Selective serotonin reuptake inhibitors for stroke recovery: a systematic review and meta-analysis. Stroke 44(3): 844–850

    Google Scholar 

  • Miller M, Swanson SA, Azrael D et al (2014) Antidepressant Dose, Age, and the Risk of Deliberate Self-harm. JAMA Intern Med 174(6): 899–909

    Google Scholar 

  • Mortensen JK, Larsson H, Johnsen SP, Andersen G (2013) Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: a nationwide propensity score-matched follow-up study. Stroke 44(2): 420–442

    Google Scholar 

  • Nagele P, Duma A, Kopec M et al (2015) Nitrous oxide for treatment-resistant major depression: a proof-of-concept trial. Biol Psychiatry 78(1): 10–18

    Google Scholar 

  • Nelson JC, Delucchi KL, Schneider LS (2013) Moderators of outcome in late-life depression: a patient-level meta-analysis. Am J Psychiatry 170(6): 651–659

    Google Scholar 

  • Ostad Haji E, Mann K, Dragicevic A et al (2013) Potential cost-effectiveness of therapeutic drug monitoring for depressed patients treated with citalopram. Ther Drug Monit 35(3) :396–401

    Google Scholar 

  • Porsteinsson AP, Drye LT, Pollock BG et al; CitAD Research Group (2014) Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA 311(7): 682–691

    Google Scholar 

  • Sharma T, Guski LS, Freund N, Gøtzsche PC (2016) Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports. BMJ 352: i65

    Google Scholar 

  • Simpson HB, Foa EB, Liebowitz MR et al (2013) Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial. JAMA Psychiatry 70(11): 1190–1199

    Google Scholar 

  • Stewart JW, McGrath PJ, Blondeau C et al (2014) Combination antidepressant therapy for major depressive disorder: Speed and probability of remission. J Psychiatr Res 57: 7–14

    Google Scholar 

  • Stingl JC, Brockmöller J (2013) Personalisierte Pharmakotherapie. Evidenzbasierte Leitlinien und klinische Anwendung pharmakogenetischer Diagnostik. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56(11): 1509–1521

    Google Scholar 

  • Tadić A, Wachtlin D, Berger M et al (2016) Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression – The EMC trial. Eur Neuropsychopharmacol 26(4): 705–716

    Google Scholar 

  • Voican CS, Corruble E, Naveau S, Perlemuter G (2014) Antidepressant-Induced Liver Injury: A Review for Clinicians. Am J Psychiatry 171(4): 404–415

    Google Scholar 

  • von Wolff A, Hölzel LP, Westphal A et al (2013) Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis. J Affect Disord 144(1–2): 7–15

    Google Scholar 

  • Wang YP, Chen YT, Tsai CF et al (2014) Short-term use of serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding. Am J Psychiatry 171(1): 54–61

    Google Scholar 

  • Watts BV, Schnurr PP, Mayo L et al (2013) Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. J Clin Psychiatry 74(6): e541–550

    Google Scholar 

  • Wenzel-Seifert K, Wittmann M, Haen E (2011) QTc prolongation by psychotropic drugs and the risk of Torsades de Pointes. Dtsch Arztebl Int 108(41): 687–693

    Google Scholar 

  • WHO (World Health Organization and United Nations High Commissioner for Refugees) (2013) Assessment and Management of Conditions Specifically Related to Stress: mhGAP Intervention Guide Module (version 1.0). Geneva

    Google Scholar 

  • Zhou X, Ravindran AV, Qin B et al (2015) Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis. J Clin Psychiatry 76(4): e487–98

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Berlin

    Dr. med. F. Regen

  2. Mainz

    Prof. Dr. med. O. Benkert

Authors
  1. Dr. med. F. Regen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. O. Benkert
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Mainz

    Otto Benkert

  2. München

    Hanns Hippius

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Regen, F., Benkert, O. (2017). Antidepressiva. In: Benkert, O., Hippius, H. (eds) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-50333-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-50333-1_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-50332-4

  • Online ISBN: 978-3-662-50333-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation